Answers are grounded in this paper and cite their sources.
This analysis demonstrates the efficacy of prostaglandins in enhancing vitiligo treatment outcomes, highlighting their dual role in activating melanocytes and modulating the immune response.
This article is devoted to the analysis of the therapeutic potential of prostaglandins (PGs) in dermatology, with a particular focus on their application in vitiligo. Due to their unique properties, prostaglandins exert a complex effect: on one hand, they activate melanocytes and stimulate melanogenesis; on the other, they modulate the immune response by suppressing autoimmune reactions. The article provides a detailed examination of the mechanisms of PG action, including their role in inflammation regulation and interaction with skin receptors. The advantages of using prostaglandins in combination therapies for vitiligo are discussed, particularly in conjunction with phototherapy, microneedling, and laser-based methods. Evidence is presented demonstrating the high efficacy of prostaglandins in the treatment of vitiligo, especially in resistant forms of the disease. The paper emphasizes that the use of PGs may significantly enhance the effectiveness of vitiligo treatment by increasing repigmentation stability and ensuring more consistent clinical outcomes. The authors also highlight the need for further research to optimize dosages, treatment regimens, and duration of prostaglandin therapy. The literature search methodology included a systematic review of scientific publications from 1987 to 2025 in databases such as PubMed, Scopus, Web of Science, and eLIBRARY.ru.
No takes yet. Share an insight, caveat, or question.
Djahaia et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: